For high-risk adult patients
For hyperuricemic adult patients
CLL=chronic lymphocytic leukemia; SLL=small lymphocytic lymphoma.
Overall adult patient population
96% of ELITEK adult patients (n=275) achieved uric acid levels ≤2 mg/dL within 4 hours after their first dose vs 0% with allopurinol1,4
*Plasma uric acid AUC from Day 1 through Day 7 was significantly lower for ELITEK and ELITEK + allopurinol than for allopurinol alone (P<0.001).1
WARNING: HYPERSENSITIVITY REACTIONS, HEMOLYSIS, METHEMOGLOBINEMIA, AND INTERFERENCE WITH URIC ACID MEASUREMENTS